-
Taking Drug Dosing Off Autopilot
Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.
by Marcus A. Banks
-
Reasons to Hope During the COVID-19 Pandemic
Patient advocates learned about COVID-19 and cancer in an AACR virtual forum.
by Kevin McLaughlin
-
Beating the Bully Inside
To gain control over fear of my breast cancer recurring, I called on lessons learned as a 5-year-old confronting the neighborhood bully.
by Joan Harris
-
Cancer Diagnoses and Research Continue
Amid the ongoing pandemic, Cancer Today continues to cover cancer research and treatment while also reporting on the many ways COVID-19 has impacted people with cancer.
by Kevin McLaughlin
-
Planning to Survive
Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment.
by Carly Flumer
-
Targeted Therapy for Early-Stage Lung Cancer?
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
-
Cervical Cancer Screening Guideline Updated
A new version of the American Cancer Society's cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method.
by Anna Azvolinsky
-
Support Grows for Making Transfusions a Part of Hospice
Blood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions.
by Jon Kelvey
-
A Missed Conversation
Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
-
Anal Cancer Diagnoses and Deaths Are Rising in the U.S.
Study underscores importance of early detection and prevention.
by Jane Langille
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore